Studies on ACTA2 mutations have demonstrated that mutationcarriers show various vasculopathies, including premature onset of coronary arterydisease (CAD), premature ischemic strokes (including Moyamoya disease), and familialthoracic aortic aneurysms and dissections (TAADs)[2]. The gene discussed is ACTA2; the disease is coronary artery disorder.